<?xml version="1.0" encoding="UTF-8"?>
<p id="d1e8092"> In addition, in 
 <xref rid="fig7" ref-type="fig">Fig. 7</xref> we illustrate the impact of getting vaccine against influenza on the reduction of the cumulative number of confirmed cases and cross-infected cases incorporating the effect of limited testing kits and public health interventions, that is, with different increasing rate of available detection kits 
 <inline-formula>
  <math id="d1e8101" display="inline" altimg="si202.svg">
   <msub>
    <mrow>
     <mi>r</mi>
    </mrow>
    <mrow>
     <mi>ω</mi>
    </mrow>
   </msub>
  </math>
 </inline-formula> or different decreasing rate of contact rate 
 <inline-formula>
  <math id="d1e8111" display="inline" altimg="si260.svg">
   <msub>
    <mrow>
     <mi>r</mi>
    </mrow>
    <mrow>
     <mi>c</mi>
    </mrow>
   </msub>
  </math>
 </inline-formula>. As shown in 
 <xref rid="fig6" ref-type="fig">Fig. 6</xref>, vaccination against influenza could reduce the cumulative numbers of confirmed cases and cumulative cross-infected cases, hereafter referred as the reduced confirmed cases and reduced cross-infected cases, respectively. It follows from 
 <xref rid="fig7" ref-type="fig">Fig. 7</xref>(
 <inline-formula>
  <math id="d1e8130" display="inline" altimg="si287.svg">
   <msub>
    <mrow>
     <mi>A</mi>
    </mrow>
    <mrow>
     <mn>1</mn>
    </mrow>
   </msub>
  </math>
 </inline-formula>) and (
 <inline-formula>
  <math id="d1e8141" display="inline" altimg="si288.svg">
   <msub>
    <mrow>
     <mi>A</mi>
    </mrow>
    <mrow>
     <mn>2</mn>
    </mrow>
   </msub>
  </math>
 </inline-formula>) that getting vaccinated against influenza could significantly reduce the cumulative number of confirmed cases and cross-infected cases with respect to 
 <inline-formula>
  <math id="d1e8152" display="inline" altimg="si202.svg">
   <msub>
    <mrow>
     <mi>r</mi>
    </mrow>
    <mrow>
     <mi>ω</mi>
    </mrow>
   </msub>
  </math>
 </inline-formula>. We give the specific reduction rate with respect to different 
 <inline-formula>
  <math id="d1e8162" display="inline" altimg="si202.svg">
   <msub>
    <mrow>
     <mi>r</mi>
    </mrow>
    <mrow>
     <mi>ω</mi>
    </mrow>
   </msub>
  </math>
 </inline-formula> and vaccination coverage rate in 
 <xref rid="tbl3" ref-type="table">Table 3</xref>. Specifically, when the vaccination coverage rate was 90%, the cumulative number of confirmed cases and cross-infected cases could reduce by 51.5% and 91.4% with 
 <inline-formula>
  <math id="d1e8176" display="inline" altimg="si251.svg">
   <mrow>
    <msub>
     <mrow>
      <mi>r</mi>
     </mrow>
     <mrow>
      <mi>ω</mi>
     </mrow>
    </msub>
    <mo linebreak="goodbreak" linebreakstyle="after">=</mo>
    <mn>0</mn>
    <mo>.</mo>
    <mn>1</mn>
    <mo linebreak="goodbreak" linebreakstyle="after">×</mo>
    <msubsup>
     <mrow>
      <mi>r</mi>
     </mrow>
     <mrow>
      <mi>ω</mi>
     </mrow>
     <mrow>
      <mn>0</mn>
     </mrow>
    </msubsup>
   </mrow>
  </math>
 </inline-formula>, respectively. We can further observe that the effects of getting vaccinated against influenza weakens as 
 <inline-formula>
  <math id="d1e8208" display="inline" altimg="si202.svg">
   <msub>
    <mrow>
     <mi>r</mi>
    </mrow>
    <mrow>
     <mi>ω</mi>
    </mrow>
   </msub>
  </math>
 </inline-formula> increases. It means that getting vaccinated against influenza could effectively control the outbreak of COVID-19. Moreover, mass influenza vaccination is more necessary when detection kits are severely limited and under seriously shortage of supply. In another words, mass influenza vaccination can be a much more effective control measure in mitigating the COVID-19 epidemics in the early stage with a rapid growth and the countries or areas with limited testing kits.
</p>
